Apexen Foundation Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 6 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 92.59%
(FY 2021)
- Profit 92.73%
(FY 2021)
- Ebitda 61.47%
(FY 2021)
- Net Worth 192.23%
(FY 2021)
- Total Assets 176.54%
(FY 2021)
About Apexen Foundation Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shubham Taylia and Jitendra Taylia serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018NPL105240
- Company No.
105240
- Company Classification
Private Not For Profit Company
- Incorporation Date
20 Nov 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apexen Foundation Of Medical Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Taylia  | Director | 20-Nov-2018 | Current |
| Jitendra Taylia | Director | 20-Nov-2018 | Current |
Financial Performance and Corporate Structure Insights of Apexen Foundation Of Medical Sciences.
Apexen Foundation Of Medical Sciences, for the financial year ended 2021, experienced significant growth in revenue, with a 92.59% increase. The company also saw a substantial improvement in profitability, with a 92.73% increase in profit. The company's net worth Soared by an impressive increase of 192.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apexen Foundation Of Medical Sciences?
In 2021, Apexen Foundation Of Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kumar Arch Tech Private LimitedActive 26 years 9 monthsShubham Taylia and Jitendra Taylia are mutual person
- Shri Kesariyaji Real Estate Private LimitedActive 12 years 9 months
Shubham Taylia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apexen Foundation Of Medical Sciences?
Unlock and access historical data on people associated with Apexen Foundation Of Medical Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apexen Foundation Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apexen Foundation Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
